Clinical Trial Update: Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C [Phase 3]

View source ↗

Summary

Open-label Phase 3 bridging study evaluating telaprevir in treatment-naïve and treatment-experienced Russian patients with genotype 1 chronic hepatitis C; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Genotype 1 Chronic Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2013-12-30